Background: The aim of this study was to assess the prevalence and clinical significance of extra-vascular findings in patients undergoing magnetic resonance angiography of the abdomen, pelvis and lower extremities. Materials and methods: Three hundred fifty-two patients underwent abdominal, pelvic and lower extremity 1.5 T magnetic resonance angiography. Clinically relevant vascular and extra-vascular findings were identified. Relevant vascular findings were classified as stenosis, occlusion, aneurysm, sclerosis, dissection or vasculitis. Relevant extra-vascular findings were categorized as 'safe' (Group A), intermediate -requiring additional investigation -(Group B) and malignant/endangering -requiring change of therapy (Group C). Results: A total of 2152 clinically relevant vascular findings was identified (6.1/patient). The most frequent vascular finding was femoral artery stenosis (10.6%). Four hundred fifty-one extra-vascular findings were observed (1.3/patient) and classified into Group A (78%), Group B (19.5%) and Group C findings (2.4%). The most frequent malignant findings were lung cancer, lymphoma, osteosarcoma, hepatocellular carcinoma and renal cell carcinoma (7/352 patients). Conclusions: Extravascular findings are frequently encountered in magnetic resonance angiography performed for vascular indications. Clinically relevant findings are seen in a substantial part of patients and should prompt further diagnostic work-up.
Introduction
In an aging population, atherosclerosis and subsequent sequelae such as stenosis and occlusion are associated with considerable morbidity. The prevalence of peripheral vascular disease in the general population varies from 12 to 14%, affecting up to 20% of those patients older than 70 years. [1] [2] [3] [4] [5] [6] Magnetic resonance angiography (MRA) of abdomen, pelvis and lower extremity is a common method to identify vascular pathologies of the aorta and peripheral arteries. There are several advantages of using MRA as a non-invasive, accurate three-dimensional (3D) diagnostic method without radiation in comparison to interventional, digital subtraction angiography (DSA) or computed tomography angiography (CTA). [1] [2] [3] [4] [5] MRA has become one of the primarily used imaging modalities for the assessment of aortic and peripheral arterial disease. 7 In addition to precise characterization of vascular anatomy, MRA examinations do also include portions of the abdomen, pelvis and lower extremity, underlining the potential to incidentally detect clinically relevant extravascular findings. Extra-vascular findings may cause similar clinical symptoms as vascular disease, e.g. pain. Therefore, diligent assessment of the extravascular information provided by MRA protocols may detect relevant disease.
The present study aimed to assess the incidence and clinical significance of extra-vascular findings in patients undergoing clinically indicated MRA of the abdomen, pelvis and lower extremities.
Materials and methods

Study population
In a 2-year-period, a database query of the Radiology Information System (RIS) was used to identify all patients with MRA of the abdomen, pelvis and lower extremity in series in a combined magnetic resonance (MR) exam protocol (24 months in succession). There was a follow-up period of at least 12 months for every patient. Three hundred fifty-two patients with various indications for MRA, including evaluation of the aorta, great iliac and peripheral arteries, were identified. Diseases like sclerosis (<50% luminal obstruction), stenosis (>50% luminal obstruction), occlusion (total luminal obstruction), aneurysm, dissection or vasculitis were documented. Datasets were retrieved from the PACS-System (Picture Archiving and Communication System, Centricity Radiology RA 1000, software release: 2.1.5.10 & 3.0.5.3, GE Healthcare, Milwaukee, USA) together with the final report initially linked to the MRA images. Datasets and reports were blinded except for the demographic data. Informed consent was obtained from each patient for MRA and following study analysis. This study complied with the Declaration of Helsinki, and the local ethics committee approved this type of study.
MRA scan protocol
All scans were performed using a 1.5 T MRI scanner (Symphony, Siemens Healthcare, Erlangen, Germany) in accordance to our institutional standardized MRA protocol as follows. The anatomical region which was examined (field-of-view (FOV)) included the abdomen from basal pulmonary structures, near the diaphragm, over the pelvis, lower extremity, ankle joints till the feet. The direction of MRA data acquisition was caudocranial for the first scans, cranio-caudal for native FLASH 3D (Fast Low-Angle Shot) scans and craniocaudal for the following contrast medium enhanced scans. All MRA examinations included coronal images as well as individually reformatted and saved images in various orientations.
All scans were performed with application of the intravenous contrast medium Gadovist (Gadobutrol, 1.0 mmol/ml, intravenous injection, Bayer Vital, Leverkusen, Germany). The scan was subdivided into three steps with automatic forward table movement. The patient lay supine on the MR with feet in front of the MR tube with a body-phased array, extremity leg array coils and spine extender applications. Both legs were positioned straightly and fixed. We performed a scan for the lower leg (0 mm), which was followed by a femoral (400 mm) and pelvic scan (800 mm) for general overview. After each first scan, 400 mm table movement in caudo-cranial direction was performed. Afterwards, the table moved cranio-caudal and pelvic TRUFI (true fast imaging) sequences (800 mm) were generated. Afterwards, pelvic FLASH 3D (800 m), femoral FLASH 3D (400 mm) and lower leg FLASH 3D (0 mm) sequences followed. After these steps, we applied contrast medium (Gadovist, 1flow 8 ml þ 0.7 flow 5 ml and NaCl 1.5 flow 20 ml). We began with a care bolus and started the contrast medium injection when it was visible on live online screen in the aorta. Due to different patient anatomy and flow, this step differs in some patients. The scan started cranially and sequences were generated as follows, starting with pelvic FLASH 3D (800 mm) and followed by femoral FLASH 3D (400 mm) and lower leg FLASH 3D (0 mm). Subtractions of native and contrast medium sequences were reconstructed. We created maximum intensity projection (MIP) images, with 16 images above 180
. The FLASH 3D scans were T1-weighted, time of echo (TE) and time of repetition (TR) varied (e.g. see figure legend). The settings for T2-HASTE sequences (Half Fourier Acquisition Single Shot Turbo Spin Echo, performed before contrast medium injection) were: TE about 55-98 ms and TR 1000 ms, for T1 FLASH 3D TE was 1.16-2.22 ms and TR 1.51-4.77 ms, and for TRUFI sequences TE was 2.15 ms and TR 4.3 ms. Flip angle was about [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , slice thickness about 1.3 mm. K-space was sequential for the first and elliptical centric for the following scan steps. Venous phases were acquired and fatsuppression was used if necessary. This was decided individually and depended on patient's parameters/ medical history and initial views/findings on first images during scan time. All MRA images were used for the analysis.
MRA images analysis
Reading of the images was performed in interactive 3D-mode either on the modality workstations or with the help of software utility (Syngo, software release: VA 30.A, Siemens Healthcare, Erlangen, Germany). For the retrospective analysis, images and reports were reviewed by two radiologists with 7 -and for 8-years experience of MRA (J.M.S. and W.S.) and one attending staff radiologist (J.M.) with long-term experience in MRA, not separately. If there were differences of detected or undetected findings between them (all three), agreement was achieved by consensus. Data and exams were anonymized automatically for the analysis. The study was performed at a hospital (Institute for Diagnostic and Interventional Radiology, at the highest national category (University Medical Center).
Vascular findings
The numbers and locations of clinically relevant vascular pathologies were documented. They were classified as stenosis (>50% percent luminal obstruction), occlusion (total luminal obstruction), aneurysm, atherosclerosis (moderate to severe, <50% luminal obstruction), dissection or vasculitis.
Extra-vascular findings
In addition, extra-vascular MRA findings were described and classified. Pathology or histology reports as well as additional diagnostic imaging results (such as magnetic resonance imaging (MRI), computed tomography (CT) or conventional X-ray) were incorporated into the analysis. Extra-vascular findings were subdivided into groups based on their clinical relevance (comparable to BI-RADS classification, Breast Imaging Reporting and Data System) and classification systems, which were used in former studies. 8, 9 They were classified as Group A findings, including lesions and findings with no recommendation for further diagnostics (clear diagnosis after MRA, not 'endangering'), as Group B findings, including intermediate findings and lesions requiring additional diagnostics and as Group C findings, including verified 'malignant' (e.g. endangering) lesions and findings with a change in patient's therapy (all verified by CT, ultrasound (US) and some with biopsy). Extra-vascular findings were not directly linked to the vascular findings.
Statistical analysis
Categorical variables are presented with absolute and relative frequencies. Continuous variables are expressed as mean AE SD and range. Descriptive statistics were calculated, e.g. the incidence of vascular and extra-vascular findings per patient. Finally, a cost analysis was performed for additional imaging including CT, US and biopsy.
Results
Patients
A total of 352 patients (male 65%, mean age 61 AE 10 years) was included in the study. The indications for MRA were the evaluation of aortic, iliac and femoral stenosis or atherosclerosis (51%), occlusion (7%) or aneurysm (10%) ( Table 1) . There were several patients with peripheral artery occlusive disease at different levels. Patients were affected by walking leg pain (22%) or ulcer cruris (11%). As cardiovascular risk factors patients had diabetes (type I or II) (21%), a history of smoking (19%) and hypertension (31%). No one was excluded, unavailable and no scan was non-diagnostic for this study. No patient was scanned twice and the observing team did not know before the imaging findings when they reviewed the images for the first time. There were no significant differences between first/initial reports (official reading) and the results of our retrospective analysis (p > 0.05).
Vascular findings
Altogether, 2152 clinical relevant vascular findings were observed in 352 patients (Table 2) . There were nine patients with no vascular pathology (2.6%, all were with an indication for MRA and with a suspicion of vascular pathology and corresponding medical history). The main vascular findings were common femoral artery stenosis (n ¼ 228/10.6% of 2152 findings) and occlusion (n ¼ 146/6.8%), anterior tibial artery stenosis (n ¼ 142/6.6%), common (n ¼ 129/6%) and internal iliac artery stenosis (n ¼ 129/6%; Figure 1 ) as well as renal artery stenosis (n ¼ 120/5.6%). In addition, MRA revealed 13 patients with aortic aneurysm (0.6%) (Figure 2 ), one patient with a total aortic occlusion (n ¼ 1), 95 patients with iliac artery occlusions (4.4%) (Figure 3 ), 52 patients with popliteal artery occlusions (2.4%), 180 patients with tibial artery occlusions (8.4%), 73 patients with peroneal artery occlusions (3.4%) and 4 patients with occlusions of the celiac trunk (2.8%). There was no patient with occlusion of the mesenteric arteries. Overall, we detected 6.1 vascular findings per patient.
Extra-vascular findings
Altogether, 451 extra-vascular findings were observed in 352 patients. Out of these patients, MRA detected 351 Group A (78%; no change in therapy/concept), 88 Group B (19.5%; additional diagnostics were recommended and performed, they were finally defined as 'not endangering') and 11 Group C findings (2.4%; verified 'malignant' or endangering lesions, change in patient's therapy). The main Group A extra-vascular Others were 5: aortic dissection, aortic occlusion, aortic vasculitis, internal iliac artery aneurysm, femoral superficial/common artery aneurysm, coeliac trunk occlusion, lumbal artery stenosis, y-bypass stenosis, y-bypass occlusion, femoral-popliteal-bypass stenosis (fem-pop), fempop-bypass occlusion, plantar artery stenosis and dorsalis pedis artery stenosis. findings were renal cysts (n ¼ 38/8.6% of 451 findings; Table 3 ). The main intermediate findings were lymph node enlargement (>10 mm diameter; n ¼ 21/4.7%) and suspicious intra-abdominal lesions (n ¼ 17/3.8%; Table 4 ). The main malignant (or endangering) findings (confirmed with additional diagnostics like CT, US and some with biopsy) were lung cancer (n ¼ 1, left basal, lower lobe), lymphoma (n ¼ 1), osteosarcoma (n ¼ 1), malignant melanoma (n ¼ 1) and hepatocellular carcinoma (n ¼ 1) (Figure 4 ), germ cell tumor (n ¼ 1) ( Figure 5 ) and renal cell carcinoma (n ¼ 1) (Figure 6 ). Each malignant finding had an incidence of 0.3% out of 352 patients. There were further Group C findings with an influence on patients' therapy (n ¼ 4). In this group, MRA assessed three patients with osteomyelitis (0.9%) and one patient with peritonitis (0.3%; Table 5 ). All in all, MRA revealed 1.3 extra-vascular findings per patient. The additional/following diagnostics and therapy in Group B and C after MRA did not reveal new 'primarily' undetected vascular or extra-vascular findings.
In general, vascular and extra-vascular findings do significantly more often appear in smokers, patients over 60 years, patients with diabetes and with hypertension (p < 0.05).
Costs analysis
Additional CT costs were 151.55 Euro (additional costs were 46.63 Euro for 3D reconstruction and for additional series 29.14 Euro). The costs for contrast medium in CT were 5.95 Euro for Imeron 350 per patient. Costs for ultrasound biopsy or in CT were different. Sample taking was 21.57 Euro, using CT additional 151.55 Euro and using ultrasound 11.66 Euro (one organ). Ultrasound of three more organs costs additional 4.66 Euro. These costs were without anesthesia, consumption of further material, room/staff costs or patient's stay in hospital. It is imaginable including these factors, costs would be higher. These were the basic single rates for one patient of the medical fee schedule in Germany 2012. An excerpt of the additional costs for the relevant findings and following imaging in our study is presented in Table 6 . In total, additional costs for these following diagnostics were about 25.868,83 Euro (33.777,98 US Dollar).
Discussion
MRA is an important non-invasive imaging modality that routinely guides clinical management and decisionmaking.
12-14 As previously described and confirmed by the present study, indications for MRA of the abdomen, pelvis and lower extremities comprise a wide spectrum, reaching from less serious illnesses like pulse reduction, pain and inflammation to more relevant diseases like cancer or severe trauma. [15] [16] [17] [18] It has been shown that there is a higher incidence of vascular diseases in patients presenting with clinical symptoms. 19 However, in many cases, initial findings related to the underlying disease could be responsible for the patient's symptoms. 20, 21 In this regard, the main finding of our study is that MRA of the abdomen, pelvis and lower extremities could demonstrate a high incidence of relevant vascular diseases (Table 2 ) and relevant 
Vascular findings
The prevalence of vascular findings of 6.1/patient is higher than observed in previous studies reporting a prevalence of 1.3/patient 22 and 1.9/patient. 23 In a study by Glockner et al. including 380 patients, a vascular pathology other than renal artery disease was found in 40% of the investigated patients. Consistent with our results, most of the vascular findings were aortic arteriosclerosis, renal artery disease, aortic aneurysm, iliac stenosis and occlusion, beside renal artery disease 22 (Table 2 ). In another MRA study of the aortic region by Krishnam et al., the main vascular findings were, as well as in our study, aortic aneurysm, dissection, aortic graft and intramural hematoma. 23 Most of the findings in peripheral MRA detected by Hadizadeh et al. were common, internal or external iliac artery sclerosis and femoral or popliteal artery sclerosis. 24 These findings were also often detected in our study. In addition, stenosis (>50% luminal obstruction) and occlusion of these segments were less frequently detected than sclerosis (<50% luminal obstruction), which is in common with our results. 24 In comparison between our's and the three other studies, patient's characteristics differ. For example, in one study, the patient cohort was younger, 23 in another one older, 22 in comparison to our patients. Additionally, our cohort included more patients 24 and different protocols were used. The indication for MRA varies, as our patients had more different indications for MRA than the evaluation of renal artery or aortic diseases. 22, 23 Furthermore, our analysis was more detailed and sub-classified than the former studies. Thus, we observed a higher incidence per patient in our study. This leads to the conclusion that vascular findings are common in patients, who are referred 
Extra-vascular findings
Comparable results to our investigations were seen in previous studies before. [25] [26] [27] [28] CT and MRA studies presented comprehensively relevant extra-vascular or extra-cardiac structures after examination. 20, 21, [29] [30] [31] [32] [33] Despite the detection of vascular MRA findings, there is still considerable discussion regarding the clinical role of extra-vascular findings. 23 Our study revealed a total number of 451 extra-vascular findings, which means 1.3 per patient. Comparable incidences range around 0.9 and have been reported before. 22 The majority of observed findings in our study was 'not endangering' (78%, Table 3 ) and did not need any kind of additional diagnostics or therapy. The relatively high rate of 'not endangering' findings is in concordance with prior studies focussing on extra-vascular findings. 20, 21 There is a relevant number of intermediate (Group B, Table 4 ) and malignant extra-vascular (Group C, Table 5 ) findings (22%), which required additional diagnostics or even significant changes in patients' treatment (B-C, all verified by CT, US and some with biopsy).
Intermediate lesions (Group B findings) require further diagnostics and should not be initially misconstrued as malignant. Almost 20% of the Group B findings could be finally defined as 'not endangering' after careful testing by further examinations. On the other hand, seven patients were categorized as malignant after additional diagnostics. This underlines the important role of an intermediate group regarding clinical decision making, as previously suggested by prior publications. [20] [21] [22] In this context, this study indicated 2% of 451 extravascular findings as proven malignant. This incidence acts in concert with prior studies reporting proven malignant findings ranging around 3%. 22 Former CT studies, like the one of Hunold et al., detected three malignant findings in 1812 patient cases. 20 Onuma et al. described four malignancies out of 503 patients 31 and Gufler et al. detected five highly suspicious malignant incidental findings in 131 study patients. 34 The detection of these extra-vascular findings had prognostic influence on the patient's outcome. In addition, in case of malignancy, detection of these abnormalities on a low staged level with the option of early oncological intervention and healing is essential. The major clinical relevant extra-vascular findings in our study were single tumors like osteosarcoma, renal cell carcinoma, hepatocellular carcinoma and pancreas carcinoma (2% of 352 patients). Those could be revealed before extended invasion or metastasizing and perhaps be reduced or extracted by therapy. Therefore, it is important to widespread the diagnostic focus while analyzing frequently seen vascular pathologies in MRA.
However, there is still discussion how to deal with detected lesions, which are not clear or suspicious to be malignant after MRA. 35 The potential benefit of the improvement of patient's therapy or even quality of life has to be balanced with increasing costs (Table 6) , additional examinations with invasive character and potential complications or additional radiation. [36] [37] [38] [39] Our study indicates that the majority of vascular and extra-vascular findings can be classified easily and that malignancy can be excluded with minimal effort and minor costs for health-care systems. Focussing on detected malignant lesion by MRA (Group C, Table 5 ), we suggest that the full FOV should be analyzed comprehensively. 28, 40 Our results underline the need to discuss a reliable and strict categorization of findings within MRA-examination to guide the analyzing radiologist.
Study limitations
Our study varies in the range of age, patient cohort, geography, and scan protocol in comparison to similar former MRA studies. [22] [23] [24] Follow-up period was short. Regarding MRA, limited availability and scan time duration reduces general usage for emergency patients extensively. Future cost reduction for the health care system and new techniques like Real-Time MRI [41] [42] [43] [44] and MR-capable catheter systems 14 could elevate the quality rating of MRA in Real-Time or emergency settings as well as of simultaneous interventional treatment in MR. This is not a comparative study between two imaging modalities or group of patients. Retrospective reading in this study was performed by analyzing initial MRA exams. Additionally, all images were analyzed retrospectively again. There was no analysis as to the best to detect extra-vascular findings. The best method seems to be evaluating a finding with all generated images and possible following diagnostic methods to finalize the decision. This study theme seems to be important for daily routine in context of medical sub-specialities (different sub-specialities, others than radiologists, try to perform MRI without extensive radiological education/experiences) and legal meanings (the fear of missing a relevant finding or just 'overlooking' and following legal/financial consequences). MRA and CTA are based on different techniques, magnetism vs. X-ray. Not every patient is able to get an MRA, due to contraindications (like implanted metal or claustrophobia). MRA is not available in nearly every hospital and usually takes more time for an examination. Usually, CTA is faster and cheaper, but does not show flow dynamics and softtissue anatomy as good as MRA. Thus, it always depends on the clinical question (indication) and the technical setting of clinical centers to know which is in a special moment the best diagnostic method for a single patient with e.g. leg pain. Additionally, ultrasound could be useful as first-line method to e.g. detect a simple thrombus. All imaging methods have theirs strengths and weaknesses. On the one hand, flow dynamics and soft tissue analysis could be better visible in MRA, on the other hand, CTA offers relatively fast imaging with high spatial and temporal resolution. The exact spatial resolution could be more detailed in CTA. This study was a diagnostic imaging study and did not include the final outcome after a long-term follow-up period (like general survival).
In conclusion, our results indicate that relevant vascular and extra-vascular findings are common in patients transferred to MRA of the abdomen, pelvis and lower extremities. The majority of these findings can be categorized after the first examination; several findings need further diagnostic work-up and could be malignant. Radiologists have to be aware of relevant vascular and extra-vascular findings that might require additional treatment. A strategy of interdisciplinary reading could be recommendable.
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